Metastatic basal cell carcinoma of the skin : Metastasis to the skeletal system producing myelophthisic anemia - 07/10/17
Doi : 10.1016/S0190-9622(82)70146-X
Charles Kleinberg, M.D. ⁎, Remedios B. Penetrante, M.D., Halina Milgrom, M.D., John W. Pickren, M.D.
From the Department of Dermatology and Pathology, Roswell Park Memorial Institute, New York State Department of Health.
aReprint requests to: Dr. Charles Kleinberg, Department of Dermatology, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, NY 14263.
Résumé |
In the typical patient with a metastasizing basal cell carcinoma, the tumor is large, ulcerated, and has been neglected. Recurrences are common, and the tumor is usually refractory to all modalities of treatment. Our patient neglected to seek medical help for 10 years, at which time metastases were already present. Our case is unique because the metastases to the skeletal system produced a myelophthisic anemia.
Le texte complet de cet article est disponible en PDF.© 1982
Publié par Elsevier Masson SAS.
Vol 7 - N° 5
P. 655-659 - novembre 1982 Retour au numéro
Article précédent
- Immune modulation by epidermal cell products: Possible role of ETAF in inflammatory and neoplastic skin diseases
- Daniel N. Sauder, Stephen I. Katz
- Palmoplantar pustular psoriasis provoked by lithium therapy
- Stephen W. White
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?